Neonatal sepsis remains a major health challenge in Africa, requiring innovative research and robust clinical trials to improve treatment and outcomes. However, involving newborns in such trials is complex, and

The SNIP-AFRICA General Assembly meeting was held from 27-28 March 2025, in Dar Es Salaam, Tanzania, bringing together representatives from 12 institutions across Africa and Europe, delegates from the Bill

We are proud to announce that SNIP-AFRICA will be featured as a case study during an EDCTP-organised event on antimicrobial resistance at the Science Summit 2024, which will be held

Every year, on September 13th, we observe World Sepsis Day, an important date in the calendar to raise awareness about sepsis – a life-threatening condition that occurs when the body’s

Newborns are usually not included in clinical trials for the development of antimicrobial drugs, which means there is very little information on how these drugs should be dosed for them.

Engaging key stakeholders, including clinical staff, families, communities, parent support groups, regulators and ethics experts, is crucial for the success of trials with novel or complex designs, especially those targeting

On 30-31 January 2024, partners in the SNIP-AFRICA project came together in Johannesburg, South Africa, for their first in-person meeting which formally kicks off project activities. Representatives from all 12

In an era marked by increasing antimicrobial resistance, which threatens the effectiveness of commonly used antibiotic treatments for childhood infections and sepsis, projects like SNIP-AFRICA stand out as examples of

On 20 September 2023, the Global Antibiotic Research & Development Partnership (GARDP) hosted a REVIVE webinar focusing on clinical trial platforms for new and neglected antimicrobials. The webinar was organised